Primary pediatric heart tumor

Summary

Primary pediatric heart tumor (MONDO:0019494) is a cancer. A subtype of heart neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Prevalence: Unknown (Worldwide)

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	primary pediatric heart tumor
Mondo ID	MONDO:0019494
Orphanet	875
UMLS	C4274356
MedGen	895113
GARD	0018710
Is cancer (heuristic)	yes

Also known as: Cardiac tumor of child · Cardiac tumour of child · heart tumor of child · heart tumour of child · paediatric heart neoplasm · pediatric heart neoplasm

Disease family

This is a subtype of heart neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › heart disorder › heart neoplasm › primary pediatric heart tumor

Related subtypes (9): heart cancer, heart malignant hemangiopericytoma, familial atrial myxoma, primary adult heart tumor, cardiac germ cell tumor, neoplasm of endocardium, neoplasm of epicardium, neoplasm of myocardium, benign neoplasm of heart

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.